The Relative Strength (RS) Rating for Alcon stock jumped into a new percentile Wednesday, as it got a lift from 70 to 74.
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
History shows that the stocks that go on to make the biggest gains often have an RS Rating of over 80 in the early stages of their moves. See if Alcon stock can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Is Alcon Stock A Buy?
Alcon stock is working on a consolidation with a 101.10 buy point. See if the medical stock can clear the breakout price in heavy trade. This is not the time to buy stocks during a market correction, but build a watchlist of possible emerging leaders once the market trend turns around.
While the company's bottom line growth fell in the company's most recent performance report from 23% to 3%, sales rose 6%, up from 5% in the previous report.
Alcon stock holds the No. 15 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Penumbra are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
